|Bid||121.72 x 900|
|Ask||121.74 x 800|
|Day's Range||121.25 - 121.85|
|52 Week Range||78.49 - 123.43|
|Beta (3Y Monthly)||0.34|
|PE Ratio (TTM)||85.20|
|Earnings Date||Oct 17, 2019 - Oct 21, 2019|
|Forward Dividend & Yield||2.98 (2.46%)|
|1y Target Est||123.73|
A former vice chairman of Procter & Gamble Co. has joined the board of IRI, a global firm focused on big data, predictive analytics and forward-looking insights for consumer, retail and media companies.
As was widely expected, the Federal Reserve lowered interest rates today by 25 basis points, but that wasn't enough to spark upside for equities. Nor was it enough for President Donald Trump who criticized the Fed for lacking "sense" and "vision" because it didn't lower rates by 50 basis points.Source: rafapress / Shutterstock.com Three Fed governors voted against today's rate cut, prompting some investors to express concern about the path forward."In determining the timing and size of future adjustments to the target range for the federal funds rate, the Committee will assess realized and expected economic conditions relative to its maximum employment objective and its symmetric 2 percent inflation objective," the Federal Open Market Committee wrote in a statement.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThis assessment will take into account a wide range of information, including measures of labor market conditions, indicators of inflation pressures and expectations, and readings on financial and international developments.So today the Nasdaq Composite slipped 0.1% while the S&P 500 added just 0.03%. The Dow Jones Industrial Average gained 0.1%. In late trading, half of the Dow stocks were pointed higher. The only sector in the U.S. that closed higher today was, unsurprisingly, utilities. Small Winners CircleThere weren't many Dow winners today and among that small group, the gains were, well, small. One surprise was JPMorgan Chase (NYSE:JPM). Financial services stocks usually benefit from higher interest rates, and JPM and its rival banks have recently been complaining about the effects lower rates have on their net interest margins. In late trading JPM was the only financial services name in the Dow trading higher. * 7 CBD Stocks to Buy That Are Still Worth Your Investment Dollars Another surprise, though of the disappointing variety, was Merck (NYSE:MRK). This Dow component barely nudged higher despite some encouraging news about its Keytruda cancer treatment. Regulators in Australia, Canada and the U.S. approved Keytruda to treat advanced endometrial carcinoma.This is significant news, but the stock barely moved higher today. Hey, it's not everyday three major developed markets approve a cancer treatment on the same day."Merck said regulators approved the use of Keytruda with a drug called Lenvima, discovered by the Japanese company Eisai (OTCMKTS:ESALY), to treat some instances of advanced endometrial carcinoma, a serious condition for which patients currently have few options," Josh Nathan-Kazis wrote for Barron's.Procter & Gamble (NYSE:PG) was a Dow winner today, and like the others, it was in modest fashion. P&G is one of the Dow's best-performing names this year. And some traders are getting bullish about options on the consumer goods giant's shares. Apple, AgainYes, Apple (NASDAQ:AAPL) has been making a lot of appearances here in recent days -- and the iPhone maker is back today. Wedbush released a note earlier today forecasting 185 million in iPhone 11 shipments for fiscal 2020. Analysts also wrote that pre-orders for the phone in the U.S. have been strong.Up nearly 8% this month, Apple has been one of the best-performing Dow stocks in September. Bottom Line on the Dow Jones TodayIt's clear that market participants are focusing on the Fed's division. However, because the central bank did not cut by 50 basis points today, it has another 25 basis point cut in its back pocket. Chairman Jerome Powell overtly said that the Fed can deploy more rate reductions if the economy sours, which he doesn't see happening right now.Speaking of the economy, the Fed upped its 2019 gross domestic product forecast to growth of 2.2%. That's up slightly from June's estimate of 2.1%. For now, the central bank is standing firm on its forecast of 2% GDP growth in 2020.As of this writing, Todd Shriber does not own any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 CBD Stocks to Buy That Are Still Worth Your Investment Dollars * 5 Stocks to Buy With Great Charts * 5 Goldman Sachs Stocks to Buy with Over 20% Upside Potential The post Dow Jones Today: Fed Obliges, Stocks Don't appeared first on InvestorPlace.
We searched, using our Zacks Stock Screener, for large-cap dividend stocks investors might want to buy after the U.S. Federal Reserve cut interest rates for the second time...
Consumer staples stocks have largely fallen off the radar in recent months. Investors have been much more focused on growth as corporate earnings have pleasantly surprised, the U.S.-China trade spat showed signs of hope and the Federal Reserve decided to keep interest rates steady.Naturally, these more defensive companies haven't been especially red-hot of late. Consumer staples stocks have lagged the marketwide bounce that took shape beginning in late December. But with many other sectors starting to feel the weight of unwieldy gains, and with China trade talks yet again hitting turbulence, the sector might be ready to heat up again.Steve Azoury, founder of financial planning firm Azoury Financial, says, "Consumer staples, the products that people use every day, will always be a big part of America's economy." "The trick," he adds, is identifying the companies that "will stay innovative and update their products and services to excite their customers, and thus the stock prices for investors."Here are 17 of the best consumer staples stocks to invest in at the moment. While some of these are blue-chip stocks that should ring a bell, others are lesser-known companies that serve as the backbone of brands you may be more familiar with. Almost all of them provide varying levels of dividend income. SEE ALSO: 57 Dividend Stocks You Can Count On
DOW UPDATE Shares of Procter & Gamble and Boeing are trading higher Tuesday afternoon, though the Dow Jones Industrial Average is trading essentially flat. The Dow (DJIA) most recently, was trading 3 points higher (0.
A BBC investigation recently discovered dozens of YouTube videos promoting fake cancer cures. Could Google's YouTube lose advertisers?
A Procter & Gamble manager who lives in West Chester and is race director for the Ohio River Paddlefest intends to paddle across the heart of Scotland nonstop for 14 hours.
It’s time to #LiveRadiant – Tampax Radiant Engages the Black Community and Helps Provide Much Needed Period Information. Even in 2019, period myths, miseducation and stigma are limiting Black women from receiving the information about their bodies, and their periods, they deserve. In fact, a new study by Tampax Radiant found 25 percent of African American women who prefer pads said they prefer them because they were not taught how to use tampons.
Aurora Cannabis (NYSE:ACB) joined companies like Tilray (NASDAQ:TLRY), Canopy Growth (NYSE:CGC) and Cronos (NASDAQ:CRON) when its recent earnings report sent ACB stock on a 9% tumble.Source: Shutterstock Because of this, there has been a wide-scale bear move. The fact is that investors have been too optimistic about the growth prospects from Canada. There have also been issues with supply chains in the country as well as black market activities.So when may things change? It may take a while.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBut even before this, the ACB stock price had been under increasing pressure. Since March, the shares have gone from $10 to $5.70.Now, as for the fiscal fourth-quarter earnings report for the company, there was still lots of growth. On a quarter-over-quarter basis, revenues jumped by 52%. There was also an annual 72% ramp. * 7 Tech Stocks You Should Avoid Now Yet Wall Street wanted much more. ACB reported C$98.9 million on the top-line while the consensus was calling for C$103 million. Note that before this the company had tempered its annual guidance.Something else about the earnings report that likely weighed on Aurora Cannabis stock was the softness in the global business. Consider that there was only a 12% increase in the medical segment in Europe to C$4.5 million.InvestorPlace.com's Josh Enomoto summed things up as follows:"The cannabis market has stepped out of the honeymoon phase and into the 'show me' phase. In other words, investors are tired of hearing bedtime stories. Instead, they want some evidence that these tales are based on facts." Bad News for ACB StockAurora Cannabis stock got hit again this week, off about 4%. The reason: negative commentary from Stifel Nicolaus analyst Andrew Carter. Primarily because of the earnings report, especially with the sluggishness in foreign markets, he slapped a "sell" rating on the shares. He lowered his price target from C$7 to C$5.He also thinks the terrible sentiment in the cannabis sector will make it more difficult for Aurora Cannabis to raise more money. No doubt, this could mean that any equity offering could see substantial dilution - which could mean even further deterioration of the stock price. An Upside for ACB StockDespite all the bad news, there remain silver linings. Aurora Cannabis has the advantage of scale and a global infrastructure (there are 15 production facilities, with sales and operations in 25 countries). For example, during the quarter the company produced over 29,000 kilograms, compared to 15,590 for the prior quarter.Another advantage for Aurora Cannabis stock is that it has Nelson Peltz as a strategic advisor. He is a top activist investor who has extensive experience with consumer goods companies like Procter & Gamble (NYSE:PG), Mondelez (NASDAQ:MDLZ), and Wendy's (NASDAQ:WEN). Peltz should be invaluable in providing high-level contacts and funding resources.And finally, there is the catalyst of "Legalization 2.0." This refers to when Canada will legalize the sale of cannabis edibles, beverages and vaping products. The law will require a 60-day permit process, after which sales will be allowed.This should help to boost revenues. However, in light of the concerns with cannabis companies right now, there may not much action with Aurora Cannabis stock until next year. So for now, there is probably no rush to make a buy.Tom Taulli is the author of the book, Artificial Intelligence Basics: A Non-Technical Introduction. Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Recession-Resistant Services Stocks to Buy * 7 Hot Penny Stocks to Consider Now * 7 Tech Stocks You Should Avoid Now The post It Doesn't Look like ACB Stock Is Going Anywhere This Year appeared first on InvestorPlace.
Procter & Gamble stock trades at 24.7x its fiscal 2020 estimated core EPS of $4.85. The stock trades at 23.2x its fiscal 2021 estimated core EPS of $5.17.
PG stock is not the sort of stock that investors would expect to lead the stock market. But in the past 12 months, Procter & Gamble stock has soared 43%. The S&P; 500 is up less than 2%.
Church & Dwight (CHD) stock has risen 9.5% on a YTD (year-to-date) basis as of September 13. However, the stock lags its peers by a wide margin.
DOW UPDATE Dragged down by declines for shares of American Express and Procter & Gamble, the Dow Jones Industrial Average is down Monday morning. Shares of American Express (AXP) and Procter & Gamble (PG) have contributed to the index's intraday decline, as the Dow (DJIA) was most recently trading 119 points, or 0.
Secret Deodorant, a longtime champion of women’s equality and advocate for women in sports, announced today that it will continue to support female soccer players by helping to boost attendance and revenue at upcoming National Women’s Soccer League (NWSL) games. With this move, Secret is doubling-down on its efforts to heighten visibility for teams and grow the fan base of the elite professionals who play in the NWSL. Beginning tomorrow, September 17, through the close of the 2019 season, Secret will purchase a total of 9,000 tickets to nine NWSL games, filling 1,000 seats at one home game for each of the nine teams, and committing more than $200,000 to the effort.
Procter & Gamble intends to buy thousands of tickets at soccer stadiums around the country where women play professionally, hoping to boost game attendance and team revenue while promoting the players along with one of P&G;’s brands.
Each day, Benzinga takes a look back at a notable market-related moment that occurred on this date. What Happened On this day 23 years ago, Gillette bought Duracell for $7 billion. Where The Market Was ...
Procter & Gamble is taking advertising to the next level by creating content with National Geographic in a six-part documentary series that seeks to draw attention to the root causes of poverty.
The Zacks Analyst Blog Highlights: Microsoft, Merck, Procter & Gamble, United Technologies and Coca-Cola
Procter & Gamble's (PG) focus on improving its product portfolio through strategic initiatives bodes well. Also, the company is on track with its cost-saving plans.